Phio Pharmaceuticals Announces Participation in Third Annual DealFlow Discovery Conference

About this update from Phio Pharmaceuticals Corp.

[{"type":"text","content":"Phio's Presentation to take place on Wednesday January 28, 2026 at 9 AM ET","length":78,"tagName":"p","attribs":{"class":"nfSubHeading"},"className":""},{"type":"text","content":"King of Prussia, Pennsylvania--(Newsfile Corp. - January 26, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today announced that it will participate in the DealFlow Discovery Conference, taking place January 28-29, 2026 at the Borgata Hotel in Atlantic City, NJ.","length":434,"tagName":"p"},{"type":"text","content":"Robert Bitterman, CEO and Chairman of the Board of Phio Pharmaceuticals will deliver a company presentation on January 28th at 9 AM in Borgata Hotel Room #1 and the management team will be available for one-on-one investor meetings throughout the event.","length":253,"tagName":"p"},{"type":"text","content":""All investors are invited to join this event to learn more about Phio Pharmaceuticals and our continuing pursuit towards a cancer free future using our INTASYL technology," stated Robert Bitterman, CEO and Chairman of Phio Pharmaceuticals. "Completion of treatment in the Phase 1b trial for PH-762 marks a significant step forward in advancing a promising treatment option for skin cancer."","length":411,"tagName":"p"},{"type":"text","content":"Event Details are as follows:","length":29,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"3rd Annual DealFlow Discovery Conference","length":40,"tagName":"p"}]},{"val":[{"type":"text","content":"The Borgata Hotel, Casino & Spa","length":35,"tagName":"p"}]},{"val":[{"type":"text","content":"Atlantic City, NJ","length":17,"tagName":"p"}]},{"val":[{"type":"text","content":"January 28-29, 2026","length":19,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":111,"olType":false},{"type":"text","content":"Investors interested in scheduling a meeting with Phio Pharmaceuticals management team can register (Investors - DealFlow Discovery Conference) to attend the conference at no cost.","length":180,"tagName":"p"},{"type":"text","content":"About Phio Pharmaceuticals Corp.","length":32,"tagName":"p"},{"type":"text","content":"Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinica...

More updates from Phio Pharmaceuticals Corp.